Copyright Reports & Markets. All rights reserved.

Global and United States Prostate Cancer Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prostate Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 PSA Tests
    • 1.2.3 CTC Tests
    • 1.2.4 Immunohistochemistry
    • 1.2.5 PCA3 Tests
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Prostate Cancer Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital Associated Labs
    • 1.3.3 Independent Diagnostic Laboratories
    • 1.3.4 Cancer Research Institutes
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate Cancer Testing Market Perspective (2015-2026)
  • 2.2 Global Prostate Cancer Testing Growth Trends by Regions
    • 2.2.1 Prostate Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate Cancer Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate Cancer Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Cancer Testing Players by Market Size
    • 3.1.1 Global Top Prostate Cancer Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Prostate Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Prostate Cancer Testing Revenue
  • 3.4 Global Prostate Cancer Testing Market Concentration Ratio
    • 3.4.1 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Testing Revenue in 2019
  • 3.5 Key Players Prostate Cancer Testing Area Served
  • 3.6 Key Players Prostate Cancer Testing Product Solution and Service
  • 3.7 Date of Enter into Prostate Cancer Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Prostate Cancer Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2021-2026)

5 Prostate Cancer Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Prostate Cancer Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Cancer Testing Market Size (2015-2026)
  • 6.2 North America Prostate Cancer Testing Market Size by Type (2015-2020)
  • 6.3 North America Prostate Cancer Testing Market Size by Application (2015-2020)
  • 6.4 North America Prostate Cancer Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Prostate Cancer Testing Market Size (2015-2026)
  • 7.2 Europe Prostate Cancer Testing Market Size by Type (2015-2020)
  • 7.3 Europe Prostate Cancer Testing Market Size by Application (2015-2020)
  • 7.4 Europe Prostate Cancer Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Prostate Cancer Testing Market Size (2015-2026)
  • 8.2 China Prostate Cancer Testing Market Size by Type (2015-2020)
  • 8.3 China Prostate Cancer Testing Market Size by Application (2015-2020)
  • 8.4 China Prostate Cancer Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Prostate Cancer Testing Market Size (2015-2026)
  • 9.2 Japan Prostate Cancer Testing Market Size by Type (2015-2020)
  • 9.3 Japan Prostate Cancer Testing Market Size by Application (2015-2020)
  • 9.4 Japan Prostate Cancer Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Prostate Cancer Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Prostate Cancer Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Prostate Cancer Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Prostate Cancer Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Genomic Health
    • 11.1.1 Genomic Health Company Details
    • 11.1.2 Genomic Health Business Overview
    • 11.1.3 Genomic Health Prostate Cancer Testing Introduction
    • 11.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2015-2020))
    • 11.1.5 Genomic Health Recent Development
  • 11.2 OPKO
    • 11.2.1 OPKO Company Details
    • 11.2.2 OPKO Business Overview
    • 11.2.3 OPKO Prostate Cancer Testing Introduction
    • 11.2.4 OPKO Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.2.5 OPKO Recent Development
  • 11.3 Siemens Healthcare
    • 11.3.1 Siemens Healthcare Company Details
    • 11.3.2 Siemens Healthcare Business Overview
    • 11.3.3 Siemens Healthcare Prostate Cancer Testing Introduction
    • 11.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.3.5 Siemens Healthcare Recent Development
  • 11.4 DiaSorin
    • 11.4.1 DiaSorin Company Details
    • 11.4.2 DiaSorin Business Overview
    • 11.4.3 DiaSorin Prostate Cancer Testing Introduction
    • 11.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.4.5 DiaSorin Recent Development
  • 11.5 bioMeriux
    • 11.5.1 bioMeriux Company Details
    • 11.5.2 bioMeriux Business Overview
    • 11.5.3 bioMeriux Prostate Cancer Testing Introduction
    • 11.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.5.5 bioMeriux Recent Development
  • 11.6 Roche
    • 11.6.1 Roche Company Details
    • 11.6.2 Roche Business Overview
    • 11.6.3 Roche Prostate Cancer Testing Introduction
    • 11.6.4 Roche Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.6.5 Roche Recent Development
  • 11.7 MDx Health
    • 11.7.1 MDx Health Company Details
    • 11.7.2 MDx Health Business Overview
    • 11.7.3 MDx Health Prostate Cancer Testing Introduction
    • 11.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.7.5 MDx Health Recent Development
  • 11.8 Beckman Coulter
    • 11.8.1 Beckman Coulter Company Details
    • 11.8.2 Beckman Coulter Business Overview
    • 11.8.3 Beckman Coulter Prostate Cancer Testing Introduction
    • 11.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.8.5 Beckman Coulter Recent Development
  • 11.9 Myriad Genetics
    • 11.9.1 Myriad Genetics Company Details
    • 11.9.2 Myriad Genetics Business Overview
    • 11.9.3 Myriad Genetics Prostate Cancer Testing Introduction
    • 11.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.9.5 Myriad Genetics Recent Development
  • 11.10 Ambry Genetics
    • 11.10.1 Ambry Genetics Company Details
    • 11.10.2 Ambry Genetics Business Overview
    • 11.10.3 Ambry Genetics Prostate Cancer Testing Introduction
    • 11.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2015-2020)
    • 11.10.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Prostate Cancer Testing Scope and Market Size
    Prostate Cancer Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    PSA Tests
    CTC Tests
    Immunohistochemistry
    PCA3 Tests
    Others

    Market segment by Application, split into
    Hospital Associated Labs
    Independent Diagnostic Laboratories
    Cancer Research Institutes
    Others

    Based on regional and country-level analysis, the Prostate Cancer Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Prostate Cancer Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Genomic Health
    OPKO
    Siemens Healthcare
    DiaSorin
    bioMeriux
    Roche
    MDx Health
    Beckman Coulter
    Myriad Genetics
    Ambry Genetics

    Buy now